Commentary: Integrating electrodermal biofeedback into pharmacologic treatment of grand mal seizures

Thirty percent of patients with epilepsy experience seizures despite optimal anticonvulsant drug treatment. Stress is frequently identified by patients with epilepsy as a precipitant of seizures (Spector et al., 2000; Ferlisi and Shorvon, 2014). Patients also often report using countermeasures to control the seizure onset. These are typically spontaneous and individualized such as increasing arousal by walking, breathing, standing, focusing attention, changing way of thinking, and more rarely inducing relaxation (Lee and No, 2005; Hether et al., 2013). In parallel, behavioral and psychological interventions, complementing conventional therapeutic methods for the management of epileptic seizures, have gained greater clinical attention over the past decade. Among these, Biofeedback (BFK) represents a noninvasive biobehavioral treatment that enables a patient to gain volitional control over a specific physiological process. BFK has already shown its value when applied to patients with epilepsy (Sterman and Friar, 1972; Rockstroh et al., 1993; Nagai et al., 2004a; Nagai, 2011; Micoulaud-Franchi et al., 2014a,b). Scrimali et al. (2015) have rightly pointed out the potential usefulness of electrodermal biofeedback in the management of refractory epilepsy. In a single case study, they report an effect of electrodermal activity (EDA) relaxation biofeedback in reducing seizures in a patient treated for 2 years. This case study supports the necessity to expand clinical armamentarium for treatment-resistant patients with few alternatives

Self-control of epileptic seizures by nonpharmacological strategies

Despite the unpredictability of epileptic seizures, many patients report that they can anticipate seizure occurrence. Using certain alert symptoms (i.e., auras, prodromes, precipitant factors), patients can adopt behaviors to avoid injury during and after the seizure or may implement spontaneous cognitive and emotional strategies to try to control the seizure itself. From the patient's view point, potential means of enhancing seizure prediction and developing seizure control supports are seen as very important issues, especially when the epilepsy is drug-resistant. In this review, we first describe how some patients anticipate their seizures and whether this is effective in terms of seizure prediction. Secondly, we examine how these anticipatory elements might help patients to prevent or control their seizures and how the patient's neuropsychological profile, specifically parameters of perceived self-control (PSC) and locus of control (LOC), might impact these strategies and quality of life (QOL). Thirdly, we review the external supports that can help patients to better predict seizures. Finally, we look at nonpharmacological means of increasing perceived self-control and achieving potential reduction of seizure frequency (i.e., stress-based and arousal-based strategies). In the past few years, various approaches for detection and control of seizures have gained greater interest, but more research is needed to confirm a positive effect on seizure frequency as well as on QOL

Voluntary control of seizures and emotional regulation in drug resistant temporal lobe epilepsy : an exemple of skin conductance biofeedback

Parmi les patients souffrant d'épilepsie, particulièrement du lobe temporal (ELT), 30% restent résistants aux médicaments malgré l'administration optimale des traitements pharmacologiques. Le caractère imprédictible des crises est l’un des aspects les plus invalidants de la maladie. De plus, les troubles dépressifs et anxieux sont des comorbidités psychiatriques fréquemment associées à l’épilepsie et impactent encore plus négativement la qualité de vie que les crises. Les approches par biofeedback, ont démontré leur efficacité dans le contrôle des crises. Une thérapie par biofeedback sur la conductance cutanée (GSR biofeedback) a montré son efficacité sur les symptômes psychiatriques. Cependant, les mécanismes sous-tendant l’efficacité sur ces symptômes restent peu connus. L’objectif de cette thèse est de mieux comprendre ces mécanismes. Deux pistes sont explorées : une physiologique dans laquelle il existerait un effet direct du GSR biofeedback sur la régulation physiologique des émotions ; une attentionnelle, dans laquelle il y aurait un effet indirect de l’entraînement sur le contrôle de l’attention. Les études menées ont permis de montrer que les patients avec ELT présentent des réponses électrodermales aux émotions plus faibles que des témoins, mais qu'elles ne sont pas plus élevées après des séances de GSR biofeedback. En revanche, l’amélioration des symptômes anxieux et dépressifs est liée à des modifications du traitement attentionnel des informations menaçantes. Le GSR biofeedback en améliorant le contrôle attentionnel induirait une diminution de la vigilance face à la menace, conduisant à une réduction de la vulnérabilité émotionnelle chez ces patients.Among patients with epilepsy, particularly temporal lobe epilepsy (TLE), 30% remain drug-resistant despite optimal administration of pharmacological treatments. The unpredictability of seizures is one of the most disabling aspects of the disease. In addition, depressive and anxiety disorders are psychiatric comorbidities frequently associated with epilepsy and have a greater negative impact on quality of life than seizures. Biofeedback approaches have been shown to be effective in controlling seizures. A biofeedback therapy on skin conductance (GSR biofeedback) has shown its efficacy on psychiatric symptoms. However, the mechanisms underlying this efficacy remain poorly understood. The objective of this thesis is to better understand these mechanisms. Two tracks are explored: a physiological one in which there is a direct effect of GSR biofeedback on the physiological regulation of emotions; an attentional one, in which there would be an indirect effect of the training on the control of attention. The studies presented have shown that TLE patients have weaker electrodermal responses than controls but that they are not higher after GSR biofeedback sessions. In contrast, the improvement of anxiety and depressive symptoms is related to changes in the attentional processing of threatening information. GSR biofeedback by improving attentional control would lead to a decrease in alertness to threat, leading to a reduction in emotional vulnerability in these patients

Stress regulation in drug-resistant epilepsy

International audienceThe prevalence of psychological distress, especially depressive and anxiety disorders, is higher in epilepsy than in other chronic health conditions. These comorbid conditions contribute even more than epileptic seizures themselves to impaired quality of life in patients with epilepsy (PWE). The link between these comorbidities and epilepsy appears to have a neurobiological basis, which is at least partly mediated by stress through psychological and pathophysiological pathways. The impact of stress in PWE is also particularly important because it is the most frequently reported seizure trigger. It is therefore crucial for clinicians to take stress-related conditions and psychiatric comorbidities into account when managing PWE and to propose clinical support to enhance self-control of stress. Screening tools have been specially designed and validated in PWE for depressive disorders and anxiety disorders (e.g. NDDI-E, GAD-7). Other instruments are useful for measuring stress-related variables (e.g. SRRS, PSS, SCS, MHLCS, DSR-15, ERP-R, QOLIE-31) in order to help characterize the individual " stress profile " and thus orientate patients towards the most appropriate treatment. Management includes both pharmacological treatment and nonpharmacological methods for enhancing self-management of stress (e.g. mindfulness-based therapies, yoga, cognitive-behavioral therapies, biofeedback), which may not only protect against psychiatric comorbidities but also reduce seizure frequency

Electroencephalographic neurofeedback: Level of evidence in mental and brain disorders and suggestions for good clinical practice

National audienceThe technique of electroencephalographic neurofeedback (EEG NF) emerged in the1970s and is a technique that measures a subject's EEG signal, processes it in real time, extractsa parameter of interest and presents this information invisual or auditory form. The goal isto effectuate a behavioural modification by modulating brain activity. The EEG NF opens therapeutic possibilities in the fields of psychiatry and neurology. However, the development of EEG NF in clinical practice requires (i) a good level of evidence of therapeutic efficacy of this technique, (ii) a good practice guide for this technique. Firstly, this article investigates selected trials with the following criteria: study design with controlled, randomized, and open or blind protocol, primary endpoint related to the mental and brain disorders treated and assessed with standardized measurement tools, identifiable EEG neurophysiological targets, underpinned by pathophysiological relevance. Trials were found for: epilepsies, migraine, stroke, chronic insomnia, attentional-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, major depressive disorder, anxiety disorders, addictive disorders, psychotic disorders. Secondly, this article investigates the principles of neurofeedback therapy in line with learning theory. Different underlying therapeutic models are presented didactically between two continua: a continuum between implicit and explicit learning and a continuum between the biomedical model (centred on ''the disease'') and integrative biopsychosocial model of health (centred on ''the illness''). The main relevant learning model is to link neurofeedback therapy with the field of cognitive remediation techniques. The methodological specificity of neurofeedback is to be guided by biologically relevant neurophysiological parameters. Guidelines for good clinical practice of EEG NF concerning technical issues of electrophysiology and of learning are suggested. These require validation by institutional structures for the clinical practice of EEG NF

Electroencephalographic neurofeedback: Level of evidence in mental and brain disorders and suggestions for good clinical practice

National audienceThe technique of electroencephalographic neurofeedback (EEG NF) emerged in the1970s and is a technique that measures a subject's EEG signal, processes it in real time, extractsa parameter of interest and presents this information invisual or auditory form. The goal isto effectuate a behavioural modification by modulating brain activity. The EEG NF opens therapeutic possibilities in the fields of psychiatry and neurology. However, the development of EEG NF in clinical practice requires (i) a good level of evidence of therapeutic efficacy of this technique, (ii) a good practice guide for this technique. Firstly, this article investigates selected trials with the following criteria: study design with controlled, randomized, and open or blind protocol, primary endpoint related to the mental and brain disorders treated and assessed with standardized measurement tools, identifiable EEG neurophysiological targets, underpinned by pathophysiological relevance. Trials were found for: epilepsies, migraine, stroke, chronic insomnia, attentional-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, major depressive disorder, anxiety disorders, addictive disorders, psychotic disorders. Secondly, this article investigates the principles of neurofeedback therapy in line with learning theory. Different underlying therapeutic models are presented didactically between two continua: a continuum between implicit and explicit learning and a continuum between the biomedical model (centred on ''the disease'') and integrative biopsychosocial model of health (centred on ''the illness''). The main relevant learning model is to link neurofeedback therapy with the field of cognitive remediation techniques. The methodological specificity of neurofeedback is to be guided by biologically relevant neurophysiological parameters. Guidelines for good clinical practice of EEG NF concerning technical issues of electrophysiology and of learning are suggested. These require validation by institutional structures for the clinical practice of EEG NF

Subjective and physiological response to emotions in temporal lobe epilepsy and psychogenic non-epileptic seizures

International audienceBackground: Temporal lobe epilepsy (TLE) and psychogenic non-epileptic seizures (PNES) are conditions frequently associated with dysfunction in emotional regulation leading to increased risk of affective disorders. This study investigates emotional processing with an objective measure of emotional reactivity in patients with TLE and patients with PNES.Methods: 34 patients with TLE and 14 patients with PNES were evaluated on skin conductance responses (SCR) to emotions induced by short films and compared to 34 healthy controls. An attention and a suppression condition were performed while viewing the films.Results: The both groups of patients disclosed lower SCR to emotions compared to controls, mainly in suppression condition. While TLE patients had lower SCR in attention condition than controls for fear, sadness and happiness, PNES had lower SCR only for happiness. In suppression condition, both had lower SCR than controls except for peacefulness in both groups and sadness in PNES. Subjective evaluations revealed that both patient's groups scored a higher intensity for sadness than controls in attention and lower for in fear and disgust in suppression only in TLE.Limitations: The sample size in the PNES group and the lack of a control group with similar levels of mood symptoms limited the interpretation of our results.Conclusion: As no correlation were found between SCR to emotions and scores of affective disorders, this pattern of responses might be underpinned by specific pathophysiological and cognitive mechanisms related to TLE and to PNES. Thus, therapeutic approaches targeting emotional autonomic responses can be of interest in the management of these condition

Post-traumatic stress disorder (PTSD) in patients with epilepsy

International audienc

A case-control study of skin conductance biofeedback on seizure frequency and emotion regulation in drug-resistant temporal lobe epilepsy

International audienc

Skin conductance biofeedback training in adults with drug-resistant temporal lobe epilepsy and stress-triggered seizures: A proof-of-concept study

International audienceno abstrac